Scabies pill also works against resistant lice: study
March 10, 2010Ivermectin, a pill prescribed for the skin disease known as scabies, also gets rid of hair lice that are resistant to conventional lotions, a study published on Thursday says.
Lice affects over 100 million people worldwide each year, especially children of primary school age, according to the paper, appearing in the New England Journal of Medicine.
The main treatments are diluted forms of an insecticide called permethrin and malathion, but since the 1990s lice have becoming more and more resistant to these chemicals.
That has left parents with little choice other than to be, literally, nit-pickers -- to go through their children's hair with a fine comb to haul out the parasites.
Ivermectin is a promising alternative, say French researchers who led the study.
They tested it in a trial involving 812 adults and children in 376 households in Britain, France, Ireland and Israel.
Half of the patients were treated with malathion and half with ivermectin, which was administered twice, seven days apart, at a dose of 400 microgrammes per kilo (2.2 pounds).
After two weeks, 95.2 percent of the ivermectin group were lice-free, compared with 85 percent in the malathion group.
"Ivermectin is more effective than the best anti-lice lotion, but it should be reserved for difficult, resistant cases," the study's coordinator, Olivier Chosidow of France's National Institute of Health and Medical Research (INSERM), told AFP.
Over-using the drug could make it succumb to resistance, following the same path as the lotions, he said.
(c) 2010 AFP
-
Study: lice resistant to chemical solution
Jun 15, 2006 |
not rated yet |
0
-
'LouseBuster' Instrument Shown to Kill Head Lice
Nov 06, 2006 |
not rated yet |
0
-
Study shows that suffocating head lice works in new treatment
Feb 24, 2010 |
not rated yet |
0
-
New finding about the bane of parents' lives -- head lice
Jan 27, 2009 |
not rated yet |
0
-
Wet combing more accurate than visual inspection for identifying active head lice infestation
Mar 16, 2009 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Can I forget a language?
2 hours ago
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
- More from Physics Forums - Medical Sciences
More news stories
Researchers develop new method for creating tissue engineering scaffolds
Researchers at Northwestern University have developed a new method for creating scaffolds for tissue engineering applications, providing an alternative that is more flexible and less time-intensive than current technology.
38 minutes ago |
not rated yet |
0
|
Drug halts organ damage in inflammatory genetic disorder
A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease ...
Medicine & Health / Medications
49 minutes ago |
not rated yet |
0
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...
38 minutes ago |
not rated yet |
0
|
Health experts, scientists to discuss bird flu studies
The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.
14 minutes ago |
not rated yet |
0
Cochlear implants may be safe, effective for organ transplant patients
Cochlear implants may be a safe, effective option for some organ transplant patients who've lost their hearing as an unfortunate consequence of their transplant-related drug regime, researchers report.
47 minutes ago |
not rated yet |
0
|
Hovering not hard if you're top-heavy, researchers find
Top-heavy structures are more likely to maintain their balance while hovering in the air than are those that bear a lower center of gravity, researchers at New York University's Courant Institute of Mathematical Sciences ...
Grass to gas: Researchers' genome map speeds biofuel development
Researchers at the University of Georgia have taken a major step in the ongoing effort to find sources of cleaner, renewable energy by mapping the genomes of two originator cells of Miscanthus x giganteus, a large perenn ...
C-sections linked to breathing problems in preterm infants
Research conducted at Yale School of Medicine shows that a cesarean (C-section) delivery, which was thought to be harmless, is associated with breathing problems in preterm babies who are small for gestational age.
Review: Netflix and Hulu's new scripted originals
Within just over a week, Netflix and Hulu are both debuting their first stabs at original scripted programming.
India probes Google over 'forex transactions'
Indian authorities are probing whether online giant Google broke domestic foreign-exchange transactions rules while shifting funds abroad, the Press Trust of India reported on Friday.
Germany freezes signing of disputed Internet pact
Germany on Friday halted the signing of a controversial international accord billed as a way to beat online piracy that has sparked angry protests, saying it needed more time to consider it.